1211577-99-9 Usage
Uses
Used in Organic Synthesis:
6-(difluoromethoxy)nicotinaldehyde is utilized as a key intermediate in organic synthesis for the preparation of various pharmaceutical agents and bioactive molecules. Its distinctive structure and functional groups contribute to the creation of diverse chemical entities with potential applications in different fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 6-(difluoromethoxy)nicotinaldehyde is employed as a crucial component in the development of new compounds with therapeutic potential. Its unique properties allow for the exploration of its efficacy in treating a range of conditions, making it a valuable asset in medicinal chemistry.
Used in the Treatment of Neurological Disorders:
6-(difluoromethoxy)nicotinaldehyde has been studied for its potential application in the treatment of various neurological disorders. Its specific structural features and functional groups may offer new avenues for therapeutic intervention in conditions affecting the nervous system.
Used in the Treatment of Cardiovascular Disorders:
Additionally, 6-(difluoromethoxy)nicotinaldehyde is being investigated for its potential role in addressing cardiovascular disorders. 6-(difluoromethoxy)nicotinaldehyde's unique attributes may contribute to the development of novel treatments that could improve cardiovascular health and patient outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 1211577-99-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,1,5,7 and 7 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1211577-99:
(9*1)+(8*2)+(7*1)+(6*1)+(5*5)+(4*7)+(3*7)+(2*9)+(1*9)=139
139 % 10 = 9
So 1211577-99-9 is a valid CAS Registry Number.
1211577-99-9Relevant academic research and scientific papers
NEW ANTI-MALARIAL AGENTS
-
Paragraph 0191-0192, (2021/10/15)
The present invention is related to new derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to dihydroisoquinoline derivatives useful for the preparation of a pharmaceutical for
FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF
-
, (2016/09/15)
The present invention relates to fluorinated compounds of formula I and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing the fluorinated compounds of the invention, and methods of treating fibrosis, macular degeneration, diabetic retinopathy (DR), macular edema, diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO), by administering these compounds and pharmaceutical compositions to subjects in need thereof.
